EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

American Journal of Clinical Dermatology

ISSN 1175-0561 · Springer Science and Business Media LLC

Latest articles

  1. Efficacy and Safety of SSGJ-608 in Moderate-to-Severe Plaque Psoriasis: A Pivotal Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase III Clinical Trial

    Ling Han, Haihong Qin, Xiaonian Lu, Litao Zhang, Linfeng Li, Hongfang Han, Jinyan Wang, Xinsuo Duan, Dongjie Sun, Wenlin Yang, Hong Ren, Xiaohua Wang, Chao Ci, Yu Wang, Xiuping Han, Wenhao Yin, Chunshui Yu, Min Zhang, Jianjian Zhu, Liming Wu, Zudong Meng, Tongxiang Zeng, Huiping Wang, Yunyun Shan, Yangfeng Ding, Wenli Feng, Xiaoli Zhang, Guoqiang Zhang, Qing Guo, Hao Cheng, Chao Ji, Ruihua Fang, Xiuqin Dong, Xiaofang Zhu, Tiechi Lei, Xueyuan Yang, Rong Xiao, Zhijun Liu, Xiaohua Tao, Rixin Chen

    Published: 2026-11DOI: 10.1007/s40257-026-01057-8

  2. Real-World Outcomes After Switching from Baricitinib to Ritlecitinib in Alopecia Areata: A Multicentre Retrospective Cohort Study

    Giuseppe Gallo, Isotta Giunipero di Corteranzo, Luca Cangialosi, Orsola Crespi, Luca Mastorino, Stephano Cedirian, Luca Rapparini, Francesca Pampaloni, Michela Starace, Alessandra Narcisi, Carlo Alberto Vignoli, Emanuele Trovato, Pietro Rubegni, Francesca Ambrogio, Giuseppe Milone, Caterina Foti, Nicolò Capurro, Giulia Gasparini, Francesca Prignano, Elisabetta Fulgione, Mariateresa Cantelli, Andrea Sechi, Luca Valtellini, Angelo V. Marzano, Lorenzo Ala, Alfredo Rossi, Giovanni Pellacani, Gianmarco Bigotto, Stefania Guida, Franco Rongioletti, Silvia Sanna, Laura Atzori, Laura Diluvio, Enrico Matteini, Luca Bianchi, Natale Schettini, Alessandro Borghi, Christian Ciolfi, Stefano Piaserico, Lorenzo Maria Pinto

    Published: 2026-10-30DOI: 10.1007/s40257-026-01089-0

Volumes

2026 · 932025 · 862024 · 822023 · 852022 · 872021 · 802020 · 852019 · 792018 · 842017 · 792016 · 702015 · 552014 · 552013 · 472012 · 462011 · 522010 · 732009 · 612008 · 622007 · 572006 · 512005 · 492004 · 652003 · 832002 · 682001 · 532000 · 53

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.